icon-folder.gif   Conference Reports for NATAP  
 
  EASL - The International Liver Congress 2014
49th Annual Meeting of the European
Association for the Study of the Liver
London, United Kingdom  April 9-13
Back grey_arrow_rt.gif
 
 
 
TURQUOISE-II: SVR12 RATE OF 92-96% IN 380 HEPATITIS C VIRUS GENOTYPE 1-INFECTED ADULTS WITH COMPENSATED CIRRHOSIS TREATED WITH ABT-450/r/ABT-267 AND ABT-333 PLUS RIBAVIRIN
 
 
  Reported by Jules Levin
EASL 2014 April 9-13 London, UK
 
Fred Poordad, Christophe Hezode, Roger Trinh, Kris V Kowdley, Stefan Zeuzem, Kosh Agarwal, Mitchell L Shiffman, Hans Heinrich Wedemeyer, Thomas Berg, Eric Yoshida, Xavier Forns, Sandra Lovell, Barbara Da Silva-Tillmann, Christine A Collins, Andrew L Campbell, Thomas Podsadecki On behalf of the TURQUOISE-II investigators

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif

EASL10.gif

EASL11.gif

EASL12.gif

EASL13.gif